Showing results (1-10 of 263) with videos related to
Sort By:
Pageof 27
CNS Drugs|August 2, 2022
Treatment Options in Refractory Autoimmune EncephalitisAlessandro Dinoto, Sergio Ferrari, Sara MariottoEuropean Journal of Neurology|November 3, 2022
Cerebellar involvement associated with immune checkpoint inhibitors: A systematic reviewAlessandro Dinoto, Elisa Mantovani, Sergio Ferrari, et al.Journal of Neuroimmunology|May 17, 2022
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinomaAlessandro Dinoto, Andrew McKeon, Gaetano Vattemi, et al.Therapeutic Advances in Neurological Disorders|April 8, 2026
Neuroglial markers of damage in autoimmune neurologyAlessandro Dinoto, Sara MariottoEuropean Journal of Neurology|June 29, 2022
Investigating paraneoplastic aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder through a data-driven approachAlessandro Dinoto, Giovanni Umberto Borin, Giulia Campana, et al.Frontiers in Neurology|April 11, 2022
Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated DiseaseAlessandro Dinoto, Elia Sechi, Eoin P Flanagan, et al.NPJ Parkinson'S Disease|November 3, 2024
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analysesElisa Mantovani, Alice Martini, Alessandro Dinoto, et al.Movement Disorders Clinical Practice|February 24, 2024
Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint InhibitorsAlessandro Dinoto, Milena Trentinaglia, Sara Carta, et al.Frontiers in Neurology|June 26, 2023
Investigating the association between neoplasms and MOG antibody-associated diseaseMilena Trentinaglia, Alessandro Dinoto, Sara Carta, et al.European Journal of Neurology|February 28, 2022
Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?Sara Mariotto, Sara Carta, Alessandro Dinoto, et al.Pageof 27